US 12290566
Dosing regimens and related compositions and methods
granted A61KA61K38/00A61K38/10
Quick answer
US patent 12290566 (Dosing regimens and related compositions and methods) held by Apellis Pharmaceuticals, Inc. expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Apellis Pharmaceuticals, Inc.
- Grant date
- Tue May 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K38/00, A61K38/10, A61K38/12, A61K39/3955